STUDI PENGGUNAAN EPOETIN ALFA DAN EPOETIN BETA PADA PASIEN PENYAKIT GINJAL KRONIK YANG MENJALANI HEMODIALISIS (Penelitian dilakukan di Instalasi Hemodialisis RSUD Dr. Soetomo Surabaya

DEASY MAFAZADARA, 051111215 (2015) STUDI PENGGUNAAN EPOETIN ALFA DAN EPOETIN BETA PADA PASIEN PENYAKIT GINJAL KRONIK YANG MENJALANI HEMODIALISIS (Penelitian dilakukan di Instalasi Hemodialisis RSUD Dr. Soetomo Surabaya. Skripsi thesis, UNIVERSITAS AIRLANGGA.

[img]
Preview
Text (HALAMAN DEPAN)
FF FK 44-15 Maf s - ADLN.pdf

Download (465kB) | Preview
[img] Text (BAB I)
12. BAB I PENDAHULUAN.pdf
Restricted to Registered users only

Download (265kB) | Request a copy
[img] Text (BAB II)
13. BAB II TINJAUAN PUSTAKA.pdf
Restricted to Registered users only

Download (1MB) | Request a copy
[img] Text (BAB III)
14. BAB III KERANGKA KONSEPTUAL.pdf
Restricted to Registered users only

Download (453kB) | Request a copy
[img] Text (BAB IV)
15. BAB IV METODE PENELITIAN.pdf
Restricted to Registered users only

Download (252kB) | Request a copy
[img] Text (BAB V)
16. BAB V HASIL PENELITIAN.pdf
Restricted to Registered users only

Download (773kB) | Request a copy
[img] Text (BAB VI)
17. BAB VI PEMBAHASAN.pdf
Restricted to Registered users only

Download (358kB) | Request a copy
[img] Text (BAB VII)
18. BAB VII KESIMPULAN DAN SARAN.pdf
Restricted to Registered users only

Download (346kB) | Request a copy
[img] Text (DAFTAR PUSTAKA)
19. DAFTAR PUSTAKA.pdf
Restricted to Registered users only

Download (336kB) | Request a copy
[img] Text (LAMPIRAN)
20. LAMPIRAN.pdf
Restricted to Registered users only

Download (464kB) | Request a copy
Official URL: http://lib.unair.ac.id

Abstract

BACKGROUND: Erythropoietin (EPO) is a glycoprotein hormone which controls production of red blood cell precursor. The decrease of EPO is the main cause of anemia in patients with chronic kidney disease (CKD). Erythropoiesis stimulating agents (ESAs) therapy is the first step in handling anemia in patients with CKD to substitute the lack of erythropoietin. There are several recombinant human EPO as epoetin alpha and beta. During the therapy, there are some factors influencing the process of erythropoesis and the efficacy of EPO therapy including uremic condition, infection-inflamation, oedema, and Ca x P level. OBJECTIVE: The aim of the study was to describe the use of epoetin alpha and beta including the type, dose, route, influencing factor of EPO efficacy and possibility of drug related problem (DRP). SUBJECTS AND METHODS: It was an observational study conducted in Hemodialysis Installation of Dr. Soetomo Teaching Hospital Surabaya during March to May 2015. The study has been approved by ethic committee. Criteria of inclusions of subject were patient who underwent therapy of epoetin alpha or beta, with data of Hb, SI, TIBC, Ca x P, BUN, leukocytes, weight, blood pressure, body temperature, and vascular access. RESULTS: Total sample obtained in this study were 27 patients. The type of epoetin used were epoetin alpha (51,85%), and epoetin beta (48,15%). The dose of epoetin alpha and beta received by patients were 3000 IU and 2000 IU respectively without calculating dose individually. All patients received underdose of epoetin alpha and beta. The route of therapy were SC (96,30%), and IV (3.70%). From this study, it could be observed that patients with high uremic condition had low average of Hb. Analysis of factors that affecting Hb include uremia conditions, levels of Ca x P, and edema can not be analyzed because the data less representative. Side effects that might be happened during the therapy were headache and cough.

Item Type: Thesis (Skripsi)
Additional Information: KKB KK-2 FF FK.44/15 Maf s
Uncontrolled Keywords: Erythropoietin, anemia, chronic kidney disease
Subjects: R Medicine > RS Pharmacy and materia medica
Divisions: 05. Fakultas Farmasi > Farmasi Klinis
Creators:
CreatorsNIM/NIDN
DEASY MAFAZADARA, 051111215UNSPECIFIED
Contributors:
ContributionNameNIDN/NIDK/NUP
ContributorWenny Putri Nilamsari, S.Farm., Apt.,Sp.FRSUNSPECIFIED
ContributorAditiawardana, dr. Sp.PDUNSPECIFIED
ContributorBudi Suprapti, Dr. , Apt., MSiUNSPECIFIED
Depositing User: sugiati
Date Deposited: 02 Apr 2016 14:22
Last Modified: 02 Apr 2016 14:22
URI: http://repository.unair.ac.id/id/eprint/19949
Sosial Share:

Actions (login required)

View Item View Item